SOURCE: TraceLink Inc.

TraceLink Inc.

February 17, 2015 09:00 ET

TraceLink Announces Educational Webinar Series for Pharmaceutical Manufacturers Facing US DSCSA Serialization Requirements

WAKEFIELD, MA--(Marketwired - Feb 17, 2015) - TraceLink Inc., the leader in protecting patient safety and enabling health for global Life Sciences, today announced that it will hold a series of educational webinars in February, March and April 2015 for pharmaceutical manufacturers who are seeking to better understand how and when they should begin to budget, plan and implement serialization solutions to meet upcoming deadlines under the U.S. Drug Supply Chain Security Act (DSCSA).

The first webinar in the series, US DSCSA Serialization: Why Now will be held on Wednesday February 18 at 11:00AM EST. The live session will provide drug manufacturers, contract manufacturing organizations (CMOs), contract packaging organizations (CPOs), and repackagers with an overview of US DSCSA serialization requirements; global serialization regulations impacting US serialization planning; key learnings from TraceLink serialization projects; and a roadmap that underscores the 24-month lead time needed for a successful serialization implementation.

"When we discuss DSCSA serialization requirements with pharmaceutical manufacturers, we're learning that few have a clear picture of what's actually required for a successful implementation. Companies may believe that they don't need to take action now, but the truth is that if planning doesn't start in 2015, many will be at risk of meeting 2017 deadlines," said Shabbir Dahod, president and CEO of TraceLink. "TraceLink has already helped a range of forward-thinking pharmaceutical manufacturers move beyond the first lot-level phase of DSCSA to help them address serialization requirements. This three-month webinar series is designed to share our insight and knowledge, and to equip every manufacturer with the information they need to understand how the decisions they make now to proceed or delay will impact their ability achieve serialization compliance by 2017."

Following the February 18 webinar, TraceLink will hold its second DSCSA serialization event in March, where the company will showcase a serialization case study, including actual planning and implementation insights from a leading pharmaceutical manufacturer. The third and final webinar in the series will take place in April and examine serialization implementation challenges related specifically to CMOs and CPOs. Pharmaceutical manufacturers interested in attending the February 18 event can sign up by visiting the Serialization Webinar registration page on the TraceLink website.

To learn more about meeting global pharmaceutical compliance deadlines designed to combat drug counterfeiting, and how to build a flexible global serialization, track and trace, and reporting platform for the European Union, Brazil, China and other countries, visit www.tracelink.com.

About TraceLink
TraceLink protects patients, enables health and ensures compliance for companies across the global Life Sciences supply network, including fifteen of the top-20 global pharmaceutical companies. Leading businesses trust the TraceLink Life Sciences Cloud, our Amazon AWS-based cloud application platform, to deliver complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. Winner of numerous industry awards including the Amazon AWS Global Start-Up Challenge Grand Prize and the Edison Award for Innovation in Health Management, the TraceLink Life Sciences Cloud is used by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit www.tracelink.com or follow us on LinkedIn.

TraceLink is funded by FirstMark Capital.

Contact Information

  • Media Contact:
    Laura MacSweeney
    Red Javelin Communications
    (781) 395-6420
    Email Contact